Cleveland Clinic study identified genetic anomaly associated with poor response to common asthma treatment
On Jan. 13, 2020, a new Cleveland Clinic study uncovered a genetic anomaly associated with poor response to…
Genentech drug Xolair (omalizumab) was approved
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
Disease | Energy | EPA | FDA | Life Science History
The Environmental Protection Agency required the phase-out of lead in gasoline
On Nov. 28, 1973, the Environmental Protection Agency (EPA) Administrator Russell E. Train announced the final regulations to…